openPR Logo
Press release

Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz

Rectal Cancer - Pipeline Review, H1 2018

"The Report Rectal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

About Rectal Cancer Market

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides an overview of the Rectal Cancer (Oncology) pipeline landscape.

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or family history of polyps or colorectal cancer. Rectal cancer commonly spreads to organs such as the liver and the lungs. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting. Rectal cancer treatment includes surgery, radiation therapy or chemotherapy, or a combination of these approaches

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581044

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Rectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase II, Phase I and Discovery stages are 1, 6, 4 and 1 respectively.

Rectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Request for TOC @ https://www.marketresearchreports.biz/reports/1581044/rectal-cancer-pipeline-review-h1-2018-market-research-reports/toc

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Rectal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Rectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rectal Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Rectal Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Rectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

View Report @ https://www.marketresearchreports.biz/reports/1581044/rectal-cancer-pipeline-review-h1-2018-market-research-reports

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rectal Cancer - Overview
Rectal Cancer - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Rectal Cancer - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Rectal Cancer - Companies Involved in Therapeutics Development
AbbVie Inc
Advaxis Inc
Amgen Inc
Avid Bioservices Inc
Eisai Co Ltd
Eli Lilly and Co
GlaxoSmithKline Plc
Madrigal Pharmaceuticals Inc.
Merck KGaA
NewLink Genetics Corp
Taiwan Liposome Company Ltd
Rectal Cancer - Drug Profiles
AK-109 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
axalimogene filolisbac - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bavituximab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bevacizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CRLX-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
E-7046 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
galunisertib monohydrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ganetespib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GSK-2256098 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
M-7824 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TLC-388 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
veliparib ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rectal Cancer - Dormant Projects
Rectal Cancer - Product Development Milestones
Featured News & Press Releases
Apr 23, 2014: Abbvie To Present Data On Veliparib At The 2014 American Society Of Clinical Oncology Annual Meeting
Nov 10, 2011: Synta Announces Results Show Ganetespib Sensitizes Rectal Cancer Cells To Chemoradiotherapy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Buy Now @ https://www.researchmoz.com/checkout?rep_id=1581044&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz here

News-ID: 955870 • Views: 576

More Releases from MarketResearchReports.biz

Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is

All 5 Releases


More Releases for Rectal

Colon and Rectal Cancer Drugs Market Opportunity Analysis, 2018 – 2026
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or
Rectal Cancer Pipeline Insight and Therapeutic Assessment Reviewed in 2017
Market Research Hub's latest Pharmaceutical and “Healthcare disease pipeline guide Rectal Cancer Pipeline Review”, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305532 Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a
Rectal Cancer Market : Dynamics, Segments and Supply Demand 2016-2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal
Rectal Cancer Market Is Expected To Profits by 2016 - 2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal